Literature DB >> 19811546

Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.

N K Lohiya1, R Suthar, A Khandelwal, S Goyal, A S Ansari, B Manivannan.   

Abstract

The functional success of the reversal of vas occlusion by styrene maleic anhydride (RISUG), using the solvent vehicle, Dimethyl Sulphoxide (DMSO), has been investigated. Reversal with DMSO was carried out in Wistar albino rats 90 days after bilateral vas occlusion. The body weight, organ weight, sperm characteristics, fertility test and teratology, including skeletal morphology were evaluated in vas occlusion and reversal animals and in F(1) progenies to assess the functional success of the occlusion and reversal. Body weight, organ weight and the cauda epididymal sperm characteristics of vas occlusion and reversal animals and of F(1) progenies were comparable to control. Ejaculated spermatozoa in the vaginal smear showed detached head/tail, acrosomal damage, bent midpiece, bent tail and morphological aberrations in sperm head after vas occlusion, which returned to normal, 90 days after reversal. Monthly fertility test, post-injection showed 0% fertility, which improved gradually and 100% fertility was achieved 90 days after reversal. The fertility/pregnancy/implantation record and skeletal morphology of the offspring were comparable to control. The results suggest functional success and safety of vas occlusion reversal by DMSO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811546     DOI: 10.1111/j.1365-2605.2009.00992.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  8 in total

Review 1.  New frontiers in nonhormonal male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Contraception       Date:  2010-05-06       Impact factor: 3.375

Review 2.  RISUG: an intravasal injectable male contraceptive.

Authors:  N K Lohiya; I Alam; M Hussain; S R Khan; A S Ansari
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

3.  Contraception with RISUG® and functional reversal through DMSO and NaHCO3 in male rabbits.

Authors:  Abdul S Ansari; Ayesha Badar; Krithika Balasubramanian; Nirmal K Lohiya
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285

4.  Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.

Authors:  Radhey Shyam Sharma; Ajit Kumar Mathur; Rajeev Singh; Hem Chandra Das; Gulshan Jeet Singh; Devinder Pal Singh Toor; Sujoy Kumar Guha
Journal:  Indian J Med Res       Date:  2019-07       Impact factor: 2.375

5.  Reversible inhibition of sperm under guidance as an intratubular and reversible contraception in female rats: An experimental study.

Authors:  Abdul Salam Ansari; Kiran Sevliya; Ayesha Badar; Nirmal Kumar Lohiya
Journal:  Int J Reprod Biomed       Date:  2021-01-25

6.  Azoospermia in rabbits following an intravas injection of Vasalgel ™.

Authors:  Donald Waller; David Bolick; Elaine Lissner; Christopher Premanandan; Gary Gamerman
Journal:  Basic Clin Androl       Date:  2016-03-30

7.  RISUG® as a male contraceptive: journey from bench to bedside.

Authors:  Barkha Khilwani; Ayesha Badar; Abdul S Ansari; Nirmal K Lohiya
Journal:  Basic Clin Androl       Date:  2020-02-13

Review 8.  Male Contraception.

Authors:  Carmen R Abbe; Stephanie T Page; Arthi Thirumalai
Journal:  Yale J Biol Med       Date:  2020-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.